ADVANCE Post Hoc Analysis: CYP2B6 Genotype Associated With Differential Weight Gain in ART-Naive Patients Initiating Efavirenz-Based ART in South Africa

March 8-11, 2020; Boston, Massachusetts
Post hoc analysis found that patients initiating EFV-based ART who were categorized by CYP2B6 genotyping as slow metabolizers had less weight gain compared with extensive metabolizers and those initiating DTG-based ART.
Format: Microsoft PowerPoint (.ppt)
File Size: 176 KB
Released: March 14, 2020

Acknowledgements

Provided by USF Health, in partnership with Clinical Care Options, LLC

USF Health
Office of Continuing Professional Development (OCPD)
124 S. Franklin Street
Tampa, FL 33602

(800) 852-5362
(813) 224-7860
(813) 224-7864 (Fax)
cpdsupport@usf.edu
https://health.usf.edu/cpd

This activity is supported by educational grants from
Gilead Sciences
Merck & Co., Inc.
ViiV Healthcare

Related Content

Expert-authored CCO slides on optimizing treatment for patients with HIV, featuring patient cases and evolving considerations for ART management

Monica Gandhi, MD, MPH
Program Director
Linda-Gail Bekker, FCP(SA), PhD Pedro Cahn, MD, PhD Laura Waters, FRCP, MD
Released: July 13, 2020

April 2020 data from Tsepamo study on NTD prevalence following dolutegravir and other ART exposure at conception from AIDS 2020 reported by CCO

Released: July 11, 2020

Latest data from a phase I trial of capsid inhibitor lenacapavir from AIDS 2020 reported by Clinical Care Options

Released: July 10, 2020

Week 96 analysis of ADVANCE trial comparing dolutegravir + FTC/(TAF or TDF) vs EFV/FTC/TDF from AIDS 2020: Virtual, reported by CCO

Released: July 10, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?